Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for ZIMMER, INC
-0.63 (-0.62%)
Nov 25 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 101.02 - 102.22
52 week 88.77 - 121.84
Open 102.18
Vol / Avg. 979,233.00/1.22M
Mkt cap 20.64B
P/E 100.73
Div/yield 0.22/0.87
EPS 1.01
Shares 203.78M
Beta 0.99
Inst. own 78%
Jan 27, 2016
Q4 2015 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:00AM EST - Add to calendar
Dec 1, 2015
Zimmer Biomet Holdings Inc at Piper Jaffray Healthcare Conference - 9:00AM EST - Add to calendar
Oct 29, 2015
Q3 2015 Zimmer Biomet Holdings Inc Earnings Call
Oct 29, 2015
Q3 2015 Zimmer Biomet Holdings Inc Earnings Release
Sep 17, 2015
Zimmer Biomet Holdings Inc at Morgan Stanley Healthcare Conference
Sep 10, 2015
Zimmer Biomet Holdings Inc at Goldman Sachs European Medtech and Healthcare Services Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 1.26% 15.39%
Operating margin 6.58% 22.14%
EBITD margin - 37.81%
Return on average assets 0.33% 7.47%
Return on average equity 0.89% 11.21%
Employees 10,000 -
CDP Score - 58 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Joseph A. Cucolo President, Americas
Age: 55
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 51
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Controller
Age: 46
Bio & Compensation  - Reuters
Derek M. Davis Vice President - Global Integration
Age: 46
Bio & Compensation  - Reuters
Larry C. Glasscock Independent Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Michael J. Farrell Director
Age: 43
Bio & Compensation  - Reuters
Michael W. Michelson Director
Age: 63
Bio & Compensation  - Reuters